Data / Crowdfunding / New Hampshire / Pirouette Pharma Inc
Pirouette Pharma Inc: crowdfunding raise on Wefunder Portal LLC, $50,000 to $2,376,381 (2026)
Pirouette Pharma Inc, a corporation in Portsmouth, NH, filed a Form C with the SEC on February 9, 2026 to raise $50,000 to $2,376,381 in Simple Agreement for Future Equity (SAFE) through Wefunder Portal LLC. The offering closed on April 30, 2026. In its most recent fiscal year it reported $0 in revenue and a net loss of $5,360,471, with 17 employees.
SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.
- Website
- pirouettepharma.com
- Funding portal
- Wefunder Portal LLC
- Address
- 200 International Drive, Suite 170, Portsmouth, NH 03801
- Legal form
- Corporation
- Jurisdiction
- DE
- Incorporated
- June 8, 2017
- SEC CIK
- 0001870611
Offering terms
From the offering filed February 9, 2026.
- Security
- Simple Agreement for Future Equity (SAFE)
- Price
- $1.00
- Target
- $50,000
- Maximum
- $2,376,381
- Deadline
- April 30, 2026
- Portal compensation
- <p>5.0% of the offering amount upon a successful fundraise, and be entitled to reimbursement for out-of-pocket third party expenses it pays or incurs on behalf of the Issuer in connection with the offering.</p>
Financials
From the Form C-AR filed April 20, 2026.
| Most recent fiscal year | Prior fiscal year | Source | |
|---|---|---|---|
| Revenue | $0 | $0 | sec.gov |
| Cost of goods sold | $0 | $0 | sec.gov |
| Net income | $-5,360,471 | $-4,050,003 | sec.gov |
| Taxes paid | $0 | $0 | sec.gov |
| Total assets | $4,374,437 | $3,878,452 | sec.gov |
| Cash | $2,076,640 | $1,610,924 | sec.gov |
| Accounts receivable | $0 | $0 | sec.gov |
| Short-term debt | $501,599 | $497,330 | sec.gov |
| Long-term debt | $13,241,055 | $7,388,869 | sec.gov |
Filings
| Filed | Filing | Target | Maximum | Deadline | Note | Source |
|---|---|---|---|---|---|---|
| April 20, 2026 | Annual report | Not listed | Not listed | sec.gov | ||
| February 9, 2026 | Offering | $50,000 | $2,376,381 | April 30, 2026 | sec.gov | |
| April 17, 2025 | Annual report | Not listed | Not listed | sec.gov | ||
| February 21, 2025 | Amendment | $50,000 | $5,000,000 | April 30, 2025 | Increasing maximum target. | sec.gov |
| January 24, 2025 | Amendment | $50,000 | $3,000,000 | April 30, 2025 | Changing legal name to Pirouette Pharma Inc. | sec.gov |
| January 16, 2025 | Amendment | $50,000 | $3,000,000 | April 30, 2025 | Increasing max target to $3M | sec.gov |
| November 7, 2024 | Amendment | $50,000 | $2,500,000 | April 30, 2025 | Increasing max target to $2.5M | sec.gov |
| June 24, 2024 | Amendment | $50,000 | $1,600,000 | April 30, 2025 | Increasing max target to $1.6M | sec.gov |
| April 17, 2024 | Amendment | $50,000 | $1,235,000 | April 30, 2025 | Adding 2023 financials and extending campaign. | sec.gov |
| January 5, 2024 | Offering | $50,000 | $1,235,000 | April 29, 2024 | sec.gov |
Also on SpecStream
Updated April 20, 2026. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.